Muhlenkamp & Co Inc Q3 2022 vs. Q4 2022 13F Holdings Comparison

The world of finance is always changing, and staying on top of those changes is vital for success in any investment strategy. One tool that investors use to keep up with these changes is the quarterly filing of Form 13F with the SEC. This form requires institutional investment managers with assets under management of more than $100 million to report their holdings in publicly traded securities.

Muhlenkamp & Co Inc is one of the many investment firms that recently submitted their Q3 2022 and Q4 2022 filings. In this article, we will compare their holdings from those two quarters and look at the changes that have taken place.

One of the most notable changes in Muhlenkamp & Co Inc's portfolio is their increased investment in Schlumberger Ltd (SLB). During Q3 2022, the firm held 314,502 shares of Schlumberger, with a value of $11,291,000. By Q4 2022, that number had decreased slightly to 314,208 shares, but the value had increased significantly to $16,797,000. This represents a 48.8% increase in value from one quarter to the next.

Another interesting change was their decreased investment in EQT Corp (EQT). During Q3 2022, Muhlenkamp & Co Inc held 446,292 shares of EQT, valued at $18,186,000. However, by Q4 2022, that number had decreased to 445,841 shares, with a value of $15,082,000. This represents a 17.1% decrease in value from the previous quarter.

Muhlenkamp & Co Inc also made small changes to their holdings in Occidental Petroleum Corp (OXY) and McKesson Corp (MCK). They increased their investment in OXY by 2.4%, going from 233,163 shares to 232,926 shares. Meanwhile, their investment in MCK increased by 10.5%, rising from 38,209 shares to 38,249 shares.

One of the most significant changes in their portfolio was the addition of 904,875 shares of ProShares Trust (PSQ) during Q4 2022. In Q3 2022, the firm did not hold any shares of this security. The value of their investment in PSQ was $13,319,000.

Muhlenkamp & Co Inc also made notable increases in their investment in Kirby Corp (KEX), Broadcom Inc (AVGO), and Micron Technology Inc (MCHP). Their investment in KEX increased by 5.8%, going from 164,549 shares to 164,395 shares. Meanwhile, their investment in AVGO increased by 25.8%, rising from 16,096 shares to 16,080 shares. Finally, their investment in MCHP increased by 15%, going from 112,136 shares to 112,024 shares.

On the other hand, Muhlenkamp & Co Inc decreased their investment in several securities. They reduced their holdings in CVS Health Corp (CVS) by 2.2%, going from 110,001 shares to 110,123 shares. Their investment in Franco-Nevada Corp (FNV.TO) also decreased by 14.4%, going from 38,314 shares to 38,385 shares. Finally, their investment in Cameco Corp (CCO.TO) decreased by 14.6%, going from 162,123 shares to 161,964 shares.

In conclusion, Muhlenkamp & Co Inc made several changes to their portfolio between Q3 2022 and Q4 2022. While they made significant increases in some securities, they also decreased their investment in others. These changes demonstrate the complex nature of the stock market and the importance of regularly reviewing and adjusting investment portfolios.